skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Macrodosimetry and microdosimetry in radioimmunotherapy

Technical Report ·
DOI:https://doi.org/10.2172/6998879· OSTI ID:6998879

This progress report summarizes the research accomplished and its clinical implementation since July 15, 1989. To improve beta-particle dosimetry, a point-source function was developed that is valid for a wide range of beta-particle emitters. An analytical solution for beta-particle dose rates within and outside of slabs of finite thickness was validated in an experimental tumor system and is now being used in clinical radioimmunotherapy (RIT). Quantitative SPECT was validated in phantom studies, beagle dogs, and patients with Kaposi's sarcoma. It is currently being used in clinical RIT for patients with Hodgkin's disease or hepatoma. Additionally, methodologies and computer software are being developed for quantitative autoradiography to achieve absorbed-dose calculation on the cellular level. 7 refs., 1 tab.

Research Organization:
Johns Hopkins Oncology Center, Baltimore, MD (USA)
Sponsoring Organization:
DOE/ER
DOE Contract Number:
FG02-89ER60867
OSTI ID:
6998879
Report Number(s):
DOE/ER/60867-1; ON: DE90007366; TRN: 90-008648
Country of Publication:
United States
Language:
English

Similar Records